Home > Products > CD28 & CD40
> Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (CrossMab)
Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-056)
Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can increase T-cell proliferation, induce DC maturation and prime efficacy of cytotoxic T cells. It is designed for the research of Acute myeloid leukaemic (AML) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (CrossMab) (CROSSAB-056). Click the button below to contact us or submit your feedback about this product.